Vaxcyte Completes Enrollment of Phase 1/2 Study Evaluating V

Vaxcyte Completes Enrollment of Phase 1/2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease (IPD) in Adults Aged 50 and Older

Vaxcyte Completes Enrollment of Phase 1/2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease (IPD) in Adults Aged 50 and Older

tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Janet Graesser , Jennifer Zibuda , Drug Administration , Nasdaq , Groupa Strep , Data Monitoring Committee , Vaxcyte Inc , Exchange Commission , Company Potential Pneumococcal Conjugate Vaccine , Sutro Biopharma Inc , Corporate Communications , Completes Enrollment , Invasive Pneumococcal Disease , Adults Aged , Immunogenicity Data , Third Quarter , Provide Coverage , Coverage Against , Grant Pickering , Chief Executive Officer , Biologics License Application , Breakthrough Therapy , Sutro Biopharma , Private Securities Litigation Reform Act , Quarterly Report , Vice President , Senior Director , Investor Relations ,